VENTRE PLAT
Food supplement declared in France, declaration No 2019-11-939
VENTRE PLAT (GR HEALTHCARE) is a food supplement declared in France. Status: retiré du marché le 30 December 2022. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- GR HEALTHCARE
- Food business operator placing the product on the market
- LABORATOIRES GRIMBERG SA
- Status
- Retiré du marché le 30 December 2022
- Form
- Gélule
- Daily dose
- 2 doses / jour (1 dose = 2 gélules)
- Directions for use
- 2 doses par jour, à prendre avec un grand verre d'eau
- Intended populations
- Homme, Femme
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans)
Declaration 298931, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retiré du marché le 30 December 2022, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Cynara scolymus L. | Feuille | Extrait sec aqueux | 400 mg |
| Humulus lupulus L. | Fleur | Extrait sec alcoolique | 80 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Argile verte montmorillonite | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Carbonate de calcium | Calcium | 2,500 mg | 800 mg |
Additives
E460, E470b, Hydroxypropyl Méthyl Cellulose
Other ingredients
maltodextrine
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
NE PAS DÉPASSER LA DOSE RECOMMANDÉE - TENIR HORS DE LA PORTÉE DES JEUNES ENFANTS - Non recommandé chez les femmes ayant des antécédents personnels ou familiaux de cancer hormonodépendant. Il est recommandé une durée d'utilisation de 15 jours, à renouveler périodiquement.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.
Brand : GR HEALTHCARE